New York Life Investment Management’s Veradigm Inc. Common Stock MDRX Stock Holding History

New York Life Investment Management’s Portfolio MDRX Stock Details MDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-26,464	Closed	-$278K	–	1576
2023 Q4	$278K	Sell	26,464 -819	-3%	-$10K	﹤0.01%	1246
2023 Q3	$358K	Sell	27,283 -4,298	-14%	-$56.4K	﹤0.01%	988
2023 Q2	$398K	Sell	31,581 -4,843	-13%	-$58.8K	﹤0.01%	1019
2023 Q1	$475K	Buy	36,424 +11,298	+45%	+$183K	0.01%	1003
2022 Q4	$443K	Buy	25,126 +2,776	+12%	+$46.5K	0.01%	1002
2022 Q3	$340K	Buy	22,350 +1,642	+8%	+$26.6K	﹤0.01%	1049
2022 Q2	$307K	Buy	+20,708	New	+$387K	﹤0.01%	1149

Other funds holding MDRX

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TCM

Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return

OFCM

One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New York Life Investment Management's MDRX Position: Q1 2024 in Review

New York Life Investment Management sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 26,464 shares — an estimated $278K sold.

New York Life Investment Management first reported a position in MDRX in Q2 2022 and held it in 7 quarters. The position peaked at $475K in Q1 2023. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

New York Life Investment Management reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
New York Life Investment Management sold 26,464 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $278K.
New York Life Investment Management first reported a position in Veradigm Inc. Common Stock in Q2 2022 and held it in 7 quarters.
New York Life Investment Management's Veradigm Inc. Common Stock position peaked at $475K in Q1 2023.
35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.